Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-27

Clinical Trial Update: FST-201 In The Treatment of Acute Fungal Otitis Externa [Phase 3]

View source ↗

Summary

Phase 3 trial of FST-201 for acute fungal otitis externa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FST-201

Snippet

Sponsor: Shire | Conditions: Acute Fungal Otitis Externa | Phase 3 | Status: TERMINATED